Literature DB >> 19828639

Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.

Séverine Boullier1, Myriam Tanguy, Khalil A Kadaoui, Cécile Caubet, Philippe Sansonetti, Blaise Corthésy, Armelle Phalipon.   

Abstract

Shigella, a Gram-negative invasive enteropathogenic bacterium responsible for bacillary dysentery, causes the rupture, invasion, and inflammatory destruction of the human colonic mucosa. We explored the mechanisms of protection mediated by Shigella LPS-specific secretory IgA (SIgA), the major mucosal Ab induced upon natural infection. Bacteria, SIgA, or SIgA-S. flexneri immune complexes were administered into rabbit ligated intestinal loops containing a Peyer's patch. After 8 h, localizations of bacteria, SIgA, and SIgA-S. flexneri immune complexes were examined by immunohistochemistry and confocal microscopy imaging. We found that anti-Shigella LPS SIgA, mainly via immune exclusion, prevented Shigella-induced inflammation responsible for the destruction of the intestinal barrier. Besides this luminal trapping, a small proportion of SIgA-S. flexneri immune complexes were shown to enter the rabbit Peyer's patch and were internalized by dendritic cells of the subepithelial dome region. Local inflammatory status was analyzed by quantitative RT-PCR using newly designed primers for rabbit pro- and anti-inflammatory mediator genes. In Peyer's patches exposed to immune complexes, limited up-regulation of the expression of proinflammatory genes, including TNF-alpha, IL-6, Cox-2, and IFN-gamma, was observed, consistent with preserved morphology. In contrast, in Peyer's patches exposed to Shigella alone, high expression of the same mediators was measured, indicating that neutralizing SIgA dampens the proinflammatory properties of Shigella. These results show that in the form of immune complexes, SIgA guarantees both immune exclusion and neutralization of translocated bacteria, thus preserving the intestinal barrier integrity by preventing bacterial-induced inflammation. These findings add to the multiple facets of the noninflammatory properties of SIgA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828639     DOI: 10.4049/jimmunol.0901838

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 2.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

3.  Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA.

Authors:  Amandine Mathias; Mélanie Duc; Laurent Favre; Jalil Benyacoub; Stephanie Blum; Blaise Corthésy
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 4.  Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.

Authors:  Prosper N Boyaka
Journal:  J Immunol       Date:  2017-07-01       Impact factor: 5.422

Review 5.  Regulation of intestinal IgA responses.

Authors:  Na Xiong; Shaomin Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

6.  Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.

Authors:  Haifeng Lu; Zhongwen Wu; Wei Xu; Jiezuan Yang; Yunbo Chen; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-02-01       Impact factor: 4.552

7.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific.

Authors:  Julia Benckert; Nina Schmolka; Cornelia Kreschel; Markus Josef Zoller; Andreas Sturm; Bertram Wiedenmann; Hedda Wardemann
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

8.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

Review 9.  The interplay between the intestinal microbiota and the immune system.

Authors:  Yuk Man Kevin Lei; Lekha Nair; Maria-Luisa Alegre
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-11-11       Impact factor: 2.947

10.  Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies.

Authors:  Stéphanie Longet; Sarah Miled; Marius Lötscher; Sylvia M Miescher; Adrian W Zuercher; Blaise Corthésy
Journal:  J Biol Chem       Date:  2012-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.